Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCa4.1, also known as KCNT1 or SLACK, is a sodium-activated potassium channel subunit that plays a crucial role in regulating neuronal excitability and ion conductance. It is primarily active in neurons within the brain, where it transports potassium ions out of cells to help maintain membrane potential and cellular homeostasis. Gain-of-function mutations in KCNT1 are associated with severe neurological disorders, including Ohtahara syndrome, malignant migrating partial seizures of infancy (MMPSI), and autosomal dominant nocturnal frontal lobe epilepsy, due to excessive neuronal firing and seizures.
Modulation of neuronal excitability via potassium ion conductance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium Calcium-Activated Channel Subfamily T Member 1 (KCa4.1).